4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
ABVC BioPharma, Inc. (ABVC) operates in the Biotechnology industry and is headquartered in Fremont, United States with about 16 employees. Its market capitalization is roughly $30 million. In the fiscal year ended 2025-12-31, ABVC reported $0M in revenue and ($8M) in net income.
ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $1M | — |
| Gross Profit | $0M | $0M | ($0M) | $1M | — |
| Operating Income (EBIT) | ($7M) | ($5M) | ($7M) | ($15M) | — |
| Net Income | ($8M) | ($5M) | ($8M) | ($16M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | ($1M) | $0M | $0M | $0M |
| Gross Profit | $0M | ($1M) | $0M | $0M | $0M |
| Operating Income (EBIT) | ($2M) | ($3M) | ($2M) | ($2M) | ($1M) |
| Net Income | ($2M) | ($4M) | ($2M) | ($2M) | ($1M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $21M | $8M | $8M | $10M | — |
| Total Liabilities | $8M | $7M | $6M | $6M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ABVC viewer.
About TickerBase · Data methodology & sources